Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 10/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | DHFR | P00374 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2461199 | 0.91 | VCAM1 (0.58) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL5992360 | 0.89 | VCAM1 (0.60) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL1896442 | 0.86 | ALDH1A1 (0.53) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL84100 | 0.85 | TSHR (0.67) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL30753177 | 0.85 | TSHR (0.67) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL1897629 | 0.84 | CRHBP (0.58) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28193869 | 0.83 | TSHR (0.64) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL9999827 | 0.81 | ALDH1A1 (0.56) | MAPTMEN1KMT2AALDH1A1LMNA | |
| SCHEMBL9808947 | 0.81 | DHFR (0.45) | VCAM1MAPTMEN1KMT2AALDH1A1 | |
| SCHEMBL10663504 | 0.81 | MAPT (0.66) | VCAM1MAPTMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7947191-B2 | Composite material composed of nanoparticles of transition metal and magnetic ferric oxide, a methode of preparing the same, and uses of the same | PEIKING UNIVERSITY (CN) | 2011-05-24 | — | — | US | disclosed |
| US-20090124834-A1 | COMPOSITE MATERIAL COMPOSED OF NANOPARTICLES OF TRANSITION METAL AND MAGNETIC FERRIC OXIDE, A METHODE OF PREPARING THE SAME, AND USES OF THE SAME | PEIKING UNIVERSITY (KR) | 2009-05-14 | — | — | US | disclosed |
| EP-1826180-A1 | A COMPOSITE MATERIAL COMPOSED OF NANOPARTICLES OF TRANSITION METAL AND MAGNETIC FERRIC OXIDE, A METHODE OF PREPARING THE SAME, AND USES OF THE SAME | Peking University (CN) | 2007-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090124834-A1 | COMPOSITE MATERIAL COMPOSED OF NANOPARTICLES OF TRANSITION METAL AND MAGNETIC FERRIC OXIDE, A METHODE OF PREPARING THE SAME, AND USES OF THE SAME | FECH, FTO, HMOX1 | VCAM1 3850/4885MAPT 2864/4885MEN1 1967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.